{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:30:54Z","timestamp":1777555854255,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.jconrel.2011.09.088","type":"journal-article","created":{"date-parts":[[2011,10,2]],"date-time":"2011-10-02T04:18:14Z","timestamp":1317529094000},"page":"366-374","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Influence of formulation variables on the biodistribution of multifunctional block copolymer micelles"],"prefix":"10.1016","volume":"157","author":[{"given":"Humphrey","family":"Fonge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Scollard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond M.","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 13","key":"10.1016\/j.jconrel.2011.09.088_bb0005","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/j.seminoncol.2004.08.003","article-title":"Use of liposomal anthracyclines in Kaposi's sarcoma","volume":"31","author":"Krown","year":"2004","journal-title":"Semin. Oncol."},{"issue":"Suppl. 2","key":"10.1016\/j.jconrel.2011.09.088_bb0010","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1634\/theoncologist.8-suppl_2-25","article-title":"Liposomal anthracyclines and new treatment approaches for breast cancer","volume":"8","author":"Wolff","year":"2003","journal-title":"Oncologist"},{"key":"10.1016\/j.jconrel.2011.09.088_bb0015","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1185\/03007990903379077","article-title":"The current role of amphotericin B lipid complex in managing systemic fungal infections","volume":"25","author":"Chu","year":"2009","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jconrel.2011.09.088_bb0020","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1038\/sj.bjc.6601856","article-title":"Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP 1049C) in patients with advanced cancer","volume":"90","author":"Danson","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2011.09.088_bb0025","doi-asserted-by":"crossref","first-page":"5855","DOI":"10.1158\/1078-0432.CCR-06-2821","article-title":"Phase I trial of poly-l-glutamate camptothecin (CT-2106) administered weekly in patients with advanced solid malignancies","volume":"13","author":"Homsi","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2011.09.088_bb0030","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/annonc\/mdh092","article-title":"Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer","volume":"15","author":"Matsumura","year":"2004","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2011.09.088_bb0035","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1038\/sj.bjc.6602204","article-title":"Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin","volume":"91","author":"Matsumura","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2011.09.088_bb0040","first-page":"145","article-title":"Recent advances with liposomes as pharmaceutical carriers","volume":"4","author":"Torchilin","year":"2005","journal-title":"Nat. Rev."},{"key":"10.1016\/j.jconrel.2011.09.088_bb0045","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.addr.2006.09.009","article-title":"Multifunctional nanocarriers","volume":"58","author":"Torchilin","year":"2006","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.jconrel.2011.09.088_bb0050","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrc1566","article-title":"Cancer nanotechnology: opportunities and challenges","volume":"5","author":"Ferrari","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2011.09.088_bb0055","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1021\/mp900201v","article-title":"Multifunctional block copolymer micelles for the delivery of 111In to EGFR-positive breast cancer cells for targeted Auger electron radiotherapy","volume":"7","author":"Fonge","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2011.09.088_bb0060","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1007\/s11095-010-0068-z","article-title":"In vivo distribution of polymeric nanoparticles at the whole-body, tumor, and cellular levels","volume":"27","author":"Lee","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2011.09.088_bb0065","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/cmmi.378","article-title":"Liposome contrast agent for CT-based detection and localization of neoplastic and inflammatory lesions in rabbits: validation with FDG-PET and histology","volume":"5","author":"Zheng","year":"2010","journal-title":"Contrast Media Mol. Imaging"},{"key":"10.1016\/j.jconrel.2011.09.088_bb0070","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1021\/mp800234r","article-title":"Quantitative CT imaging of the spatial and temporal distribution of liposomes in a rabbit tumor model","volume":"6","author":"Zheng","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2011.09.088_bb0075","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jconrel.2009.04.010","article-title":"Block copolymer micelles for delivery of cancer therapy: transport at the whole body, tissue and cellular levels","volume":"138","author":"Mikhail","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2011.09.088_bb0080","doi-asserted-by":"crossref","first-page":"6732","DOI":"10.1158\/0008-5472.CAN-05-4199","article-title":"Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models","volume":"66","author":"Kirpotin","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2011.09.088_bb0085","doi-asserted-by":"crossref","first-page":"11631","DOI":"10.1158\/0008-5472.CAN-05-1093","article-title":"Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo","volume":"65","author":"Mamot","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2011.09.088_bb0090","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0014-5793(97)00905-8","article-title":"Immunoliposomes bearing polyethyleneglycol-coupled Fab' fragment show prolonged circulation time and high extravasation into targeted solid tumors in vivo","volume":"413","author":"Maruyama","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jconrel.2011.09.088_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1088\/0957-4484\/18\/38\/385101","article-title":"Decreased circulation time offsets increased efficacy of PEGylated nanocarriers targeting folate receptors of glioma","volume":"18","author":"McNeeley","year":"2007","journal-title":"Nanotechnology"},{"key":"10.1016\/j.jconrel.2011.09.088_bb0100","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0163-7827(03)00032-8","article-title":"Ligand-targeted liposomal anticancer drugs","volume":"42","author":"Sapra","year":"2003","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.jconrel.2011.09.088_bb0105","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1021\/bc100070g","article-title":"Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects","volume":"21","author":"Maeda","year":"2010","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2011.09.088_bb0110","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/mp800051m","article-title":"Factors affecting the clearance and biodistribution of polymeric nanoparticles","volume":"5","author":"Alexis","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2011.09.088_bb0115","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.addr.2010.04.009","article-title":"The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect","volume":"63","author":"Fang","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2011.09.088_bb0120","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1126\/science.8128245","article-title":"Biodegradable long-circulating polymeric nanospheres","volume":"263","author":"Gref","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2011.09.088_bb0125","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0031-6997(24)01494-7","article-title":"Long-circulating and target-specific nanoparticles: theory to practice","volume":"53","author":"Moghimi","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jconrel.2011.09.088_bb0130","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/wnan.24","article-title":"Pharmacokinetics of nanomaterials: an overview of carbon nanotubes, fullerenes and quantum dots","volume":"1","author":"Riviere","year":"2009","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2011.09.088_bb0135","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1158\/1078-0432.CCR-08-2392","article-title":"Tumor-targeted nanomedicines: enhanced antitumor efficacy in vivo of doxorubicin-loaded, long-circulating liposomes modified with cancer-specific monoclonal antibody","volume":"15","author":"ElBayoumi","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2011.09.088_bb0140","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.bmc.2009.10.045","article-title":"Tc-99m-tricarbonyl labelled agents for cell labeling: development, biodistribution in normal mice and preliminary in vitro evaluation","volume":"18","author":"Fonge","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jconrel.2011.09.088_bb0145","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.2174\/156802610791384243","article-title":"(99m)Tc and (111)In-labeling of small biomolecules: bifunctional chelators and related coordination chemistry","volume":"10","author":"Chakraborty","year":"2010","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.jconrel.2011.09.088_bb0150","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2174\/187152007780618144","article-title":"Labeling biomolecules with radiorhenium: a review of the bifunctional chelators","volume":"7","author":"Liu","year":"2007","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.jconrel.2011.09.088_bb0155","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1007\/s00259-009-1134-9","article-title":"The influence of Bz-DOTA and CHX-A''-DTPA on the biodistribution of ABD-fused anti-HER2 affibody molecules: implications for 114mIn-mediated targeting therapy","volume":"36","author":"Tolmachev","year":"2009","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.jconrel.2011.09.088_bb0160","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1021\/mp8002418","article-title":"Non-invasive monitoring of the fate of 111In-labelled block copolymer micelles by high resolution and high sensitivity MicroSPECT\/CT imaging","volume":"6","author":"Hoang","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2011.09.088_bb0165","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.1021\/ma0607665","article-title":"Synthesis of carboxy-functionalized heterobifunctional poly(ethylene glycol) by a thiol-anionic polymerization method","volume":"39","author":"Zeng","year":"2006","journal-title":"Macromolecules"},{"key":"10.1016\/j.jconrel.2011.09.088_bb0170","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1021\/bc050350g","article-title":"Epidermal growth factor-conjugated poly(ethylene glycol)-block-poly(delta-valerolactone) copolymer micelles for targeted delivery of chemotherapeutics","volume":"17","author":"Zeng","year":"2006","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2011.09.088_bb0175","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0165-022X(95)00032-M","article-title":"Determination of surfactant critical micelle concentration by a novel fluorescence depolarization technique","volume":"31","author":"Zhang","year":"1996","journal-title":"J. Biochem. Biophys. Methods"},{"key":"10.1016\/j.jconrel.2011.09.088_bb0180","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ejpb.2006.11.010","article-title":"In vivo fate of unimers and micelles of a poly(ethylene glycol)-block-poly(caprolactone) copolymer in mice following intravenous administration","volume":"65","author":"Liu","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2011.09.088_bb0185","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/0006-291X(85)90131-7","article-title":"MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF","volume":"128","author":"Filmus","year":"1985","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2011.09.088_bb0190","first-page":"39","article-title":"Immunoliposomes for cancer therapy","volume":"8","author":"Kontermann","year":"2006","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.jconrel.2011.09.088_bb0195","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1016\/j.bmcl.2009.03.083","article-title":"Positioning of 99mTc-chelators influences radiolabeling, stability and biodistribution of affibody molecules","volume":"19","author":"Ekblad","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jconrel.2011.09.088_bb0200","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.nucmedbio.2007.01.004","article-title":"In vitro and in vivo comparison of DTPA- and DOTA-conjugated antiferritin monoclonal antibody for imaging and therapy of pancreatic cancer","volume":"34","author":"Sabbah","year":"2007","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.jconrel.2011.09.088_bb0205","first-page":"643","article-title":"111In-Bz-DTPA-hEGF: preparation and in vitro characterization of a potential anti-glioblastoma targeting agent","volume":"18","author":"Sundberg","year":"2003","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.jconrel.2011.09.088_bb0210","first-page":"2639","article-title":"Nature of the bifunctional chelating agent used for radioimmunotherapy with yttrium-90 monoclonal antibodies: critical factors in determining in vivo survival and organ toxicity","volume":"49","author":"Kozak","year":"1989","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2011.09.088_bb0215","first-page":"1235","article-title":"The molecular structure of indium-DTPA","volume":"30","author":"Maecke","year":"1989","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jconrel.2011.09.088_bb0220","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/10611860500286239","article-title":"Monoclonal antibody 2C5-mediated binding of liposomes to brain tumor cells in vitro and in subcutaneous tumor model in vivo","volume":"13","author":"Gupta","year":"2005","journal-title":"J. Drug Target"},{"key":"10.1016\/j.jconrel.2011.09.088_bb0225","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0169-409X(97)00133-6","article-title":"Receptor versus non-receptor mediated clearance of liposomes","volume":"32","author":"Kamps","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2011.09.088_bb0230","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0304-3835(97)00326-1","article-title":"Anti-HER2 immunoliposomes for targeted therapy of human tumors","volume":"118","author":"Park","year":"1997","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2011.09.088_bb0235","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1021\/bi962148u","article-title":"Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro","volume":"36","author":"Kirpotin","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.jconrel.2011.09.088_bb0240","first-page":"1172","article-title":"Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery","volume":"8","author":"Park","year":"2002","journal-title":"Clin. Cancer Res."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365911009424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365911009424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:26:00Z","timestamp":1759159560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365911009424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0168365911009424"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2011.09.088","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of formulation variables on the biodistribution of multifunctional block copolymer micelles","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2011.09.088","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}